Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.80 |
| ▸ | MEN1 | O00255 | 2/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.80 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.80 |
| ▸ | CRHBP | P24387 | 1/20 | 0.80 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.80 |
| ▸ | CDC7 | O00311 | 6/20 | 0.72 |
| ▸ | DBF4 | Q9UBU7 | 6/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.58 |
| ▸ | PPARA | Q07869 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13046766 | 0.91 | CDC7 (0.67) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL289583 | 0.89 | KDM4E (0.65) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL28297323 | 0.89 | MEN1 (0.64) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4809764 | 0.89 | MAPT (0.74) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4801129 | 0.89 | MAPT (0.78) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL8341363 | 0.89 | MAPT (0.78) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL3368828 | 0.88 | CDC7 (0.70) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL14109699 | 0.88 | KDM4E (0.62) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4804421 | 0.88 | MAPT (0.76) | MAPTMEN1KMT2AKDM4EHSP90AA1 | |
| SCHEMBL4484447 | 0.88 | MAPT (0.76) | MAPTMEN1KMT2AKDM4EHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116375663-A | Febuxostat hapten, artificial antigen and application thereof | 华南农业大学 | 2023-07-04 | — | — | CN | claimed |
| CN-116375663-B | Febuxostat hapten, artificial antigen and application thereof | 华南农业大学 | 2024-06-14 | — | — | CN | disclosed |
| US-20240166613-A1 | PROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) COMPOUNDS AND METHODS OF USING THE SAME | THE UNIVERSITY OF TOLEDO (US) | 2024-05-23 | — | — | US | disclosed |
| CN-113189842-B | Preparation method of color filter | 江苏穿越光电科技有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-11897852-B2 | Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same | THE UNIVERSITY OF TOLEDO (US) | 2024-02-13 | — | — | US | disclosed |
| CN-116375663-A | Febuxostat hapten, artificial antigen and application thereof | 华南农业大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-113189842-A | Preparation method of color filter | 尚健 | 2021-07-30 | — | — | CN | disclosed |
| US-20210163431-A1 | PROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) COMPOUNDS AND METHODS OF USING THE SAME | THE UNIVERSITY OF TOLEDO (US) | 2021-06-03 | — | — | US | disclosed |
| US-10941125-B2 | Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same | THE UNIVERSITY OF TOLEDO (US) | 2021-03-09 | — | — | US | disclosed |
| EP-3124489-B1 | THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS | FIBROGEN INC (US) | 2020-07-15 | — | — | EP | disclosed |
| EP-1324774-A2 | USE OF A PPAR DELTA ACTIVATOR FOR TREATING INFLAMMATORY CONDITIONS | GLAXO GROUP LIMITED (GB) | 2003-07-09 | — | — | EP | disclosed |
| EP-1324773-A2 | USE OF A PPAR DELTA ACTIVATOR IN THE TREATMENT OF DISEASES RELATED TO NO INHIBITION OR TNF INHIBITION | GLAXO GROUP LIMITED (GB) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002092590-A1 | FURAN AND THIOPHENE DERIVATIVES THAT ACTIVATE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | GLAXO GROUP LIMITED (GB) | 2002-11-21 | — | — | WO | disclosed |
| WO-2002062774-A1 | THIAZOLE DERIVATIVES FOR TREATING PPAR RELATED DISORDERS | GLAXO GROUP LIMITED (GB) | 2002-08-15 | — | — | WO | disclosed |
| WO-2002059098-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AS ACTIVATORS OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS | GLAXO GROUP LIMITED (GB) | 2002-08-01 | — | — | WO | disclosed |
| WO-2002050048-A1 | THIA- AND OXAZOLES AND THEIR USE AS PPARS ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2002-06-27 | — | — | WO | disclosed |
| WO-2002028434-A2 | USE OF A PPAR DELTA ACTIVATOR FOR TREATING INFLAMMATORY CONDITIONS | GLAXO GROUP LIMITED (GB) | 2002-04-11 | — | — | WO | disclosed |
| WO-2002028433-A2 | USE OF A PPAR DELTA ACTIVATOR IN THE TREATMENT OF DISEASES RELATED TO NO INHIBIT ION OR TNF INHIBITION | GLAXO GROUP LIMITED (GB) | 2002-04-11 | — | — | WO | disclosed |
| EP-1189895-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | GLAXO GROUP LIMITED (GB) | 2002-03-27 | — | — | EP | disclosed |
| WO-2001000603-A1 | THIAZOLE AND OXAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE | GLAXO GROUP LIMITED (GB) | 2001-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166613-A1 | PROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) COMPOUNDS AND METHODS OF USING THE SAME | PPARG, PPARA, PPARD | MAPT 4707/4885MEN1 4748/4885KMT2A 3888/4885 |
| US-10941125-B2 | Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same | PPARG, PPARA, PPARD | MAPT 4708/4885MEN1 4755/4885KMT2A 3920/4885 |
| US-11897852-B2 | Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same | PPARG, PPARA, PPARD | MAPT 4708/4885MEN1 4755/4885KMT2A 3920/4885 |
| US-20210163431-A1 | PROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) COMPOUNDS AND METHODS OF USING THE SAME | PPARG, PPARA, PPARD | MAPT 4708/4885MEN1 4755/4885KMT2A 3920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.